BIOSPECIFICS TECHNOLOGIES CORP

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$782.3M

793 transactions

Summary

BIOSPECIFICS TECHNOLOGIES CORP is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $657.1MSales: $108.1M27 insiders

Date	Insider	Type	Value
2020-12-02	Truitt Joseph(Chief Executive Officer)	D	$2.5M
2020-12-02	Chao Jennifer M	D	$700K
2020-12-02	HUTCHISON PATRICK(Chief Financial Officer)	D	$323K
2020-12-02	Sherman Michael A.	D	$197K
2020-12-02	Fishman Corey N.	D	$197K
2020-12-02	Chao Jennifer M	D	$164K
2020-12-02	Chao Jennifer M	D	$86K
2020-12-02	Sherman Michael A.	D	—
2020-12-02	Gitman Paul	D	—
2020-12-02	Gitman Paul	D	—
2020-12-02	Schamroth Michael	D	—
2020-12-02	Schamroth Michael	D	—
2020-12-02	Wegman Mark N	D	—
2020-12-02	Wegman Mark N	D	—
2020-12-02	Wegman Mark N	D	—
2020-12-02	Fishman Corey N.	D	—
2020-12-02	Wegman Toby	D	—
2020-12-02	Wegman Toby	D	—
2020-12-02	Wegman Toby	D	—
2020-12-02	Chao Jennifer M	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

BIOSPECIFICS TECHNOLOGIES CORP — Contributions, Lobbying & Contracts | Poliscope